large_hotel.jpg

medium_hotel.jpg

small_hotel.jpg

thumbnail_hotel.jpg

hotel.jpg

2024 Winter Clinical Dermatology Conference - Miami

large_WCM + PAMS_Fountainebleau Miami Beach_dusk.jpg

medium_WCM + PAMS_Fountainebleau Miami Beach_dusk.jpg

small_WCM + PAMS_Fountainebleau Miami Beach_dusk.jpg

thumbnail_WCM + PAMS_Fountainebleau Miami Beach_dusk.jpg

WCM + PAMS_Fountainebleau Miami Beach_dusk.jpg

2024 Patient Access Management Summit - Miami

AI may be less accurate than clinicians in usage for management decisions

AI Accurate in Diagnosing Suspicious Skin Lesions

Clinically meaningful responses seen for patients who did not achieve coprimary end point in the ECZTRA 1 and 2 trials

How Beneficial Is Tralokinumab for Patients With Atopic Dermatitis?

Incidence rates in patients with skin of color are about 10 percent of that seen for non-Hispanic Whites

Is the Incidence of Keratinocyte Carcinoma Lower for Patients of Color?

Attributable burdens were 18,960 deaths and 0.5 million disability-adjusted life years, which almost doubled from 2000 to 2019

Occupational Exposure to Solar UVR Linked to Nonmelanoma Skin Cancer

Preoperative staging with cross-sectional imaging does not influence management in localized Merkel cell carcinoma

Does Preop Staging With Imaging Impact Management of Merkel Cell Carcinoma?

More rapid onset of improvement, comparable efficacy, and good tolerability seen for M-PDT versus low-dose isotretinoin

Can Modified Photodynamic Therapy Offer Rapid Improvement of Acne?

Guidelines include strong recommendations for monoclonal antibodies and JAK inhibitors

Recommendations Developed for Atopic Dermatitis Therapies

Incorporation of religion into cultural humility training recommended, as well as dermatology education at community events

How Can Dermatology Care Be Improved for Muslim Patients?

Mohs micrographic surgery was only done on 32.3 percent of the keratinocyte carcinomas that qualified based on AUC score

Can Mohs Appropriate Use Criteria Score Help Determine Keratinocyte Carcinoma Treatment?

However, differences between acupuncture and sham acupuncture, wait-list control did not meet threshold for minimal clinically important difference

Acupuncture Offers Some Benefit in Chronic Spontaneous Urticaria

Psoriasis mechanism of disease: Genetic, environmental, and lifestyle factors

In this installment of Discourses in Dermatology, Dr. George Han, Director of Clinical Research at Northwell Health in New York, sits down with Dr. Andrew Blauvelt, Investigator at Oregon Medical Research Center, to discuss the genetic, environmental, and lifestyle factors that influence psoriasis. They also explore the comorbidities associated with psoriasis and how they play into the role of psoriatic disease.The role of genetics in psoriasisDr. Han begins by asking Dr. Blauvelt what role genetics really plays in the development of psoriasis.Dr. Blauvelt references the first genetic study published on psoriasis, spearheaded by Danish researchers in the Faroe Islands in 1963, which found evidence of a genetic component to psoriasis in the local island population. &nbsp;He also comments on a key study examining identical twins that revealed strong evidence in favor of a genetic component to psoriasis.Dr. Blauvelt notes that while there is a genetic component to psoriasis, it’s not a Mendelian disease. Rather, there are 70 to 80 susceptibility genes that have been identified that either confer a risk for psoriasis or confer some protection.With those factors considered, he explains to his patients that while there is indeed a significant genetic component, it does not account for the entire picture of psoriasis. He estimates that approximately 40% of patients have a family history of the condition but suggests that even those without a family history may still have a genetic predisposition due to a combination of genes inherited from their parents.&nbsp;To summarize, he reiterates that psoriasis is a complex condition with a genetic component with other factors also involved in its development.Key points<ul><li>A seminal study demonstrating the genetics of psoriasis was conducted by Danish researchers on the Faroe Islands in 1963</li><li>Twin studies have also revealed strong evidence in favor of a genetic component to psoriasis</li><li>Psoriasis is not a Mendelian disease, but is influenced by 70 to 80 susceptibility genes</li><li>While there is a significant genetic component to psoriasis, it does not account for the entire picture</li></ul>Environmental influences on psoriasisDr. Han continues the conversation by asking Dr. Blauvelt about the environmental influences on psoriasis that may encourage psoriasis in susceptible individuals.Dr. Blauvelt replies by giving more background on the genetics of psoriasis, explaining that there are 2 types of psoriasis as it relates to genetics. The first type is a result of genes that tend to run in families, with HLA-Cw6 being the most common. With this type, there is usually an earlier onset in the late teens or early 20s.&nbsp;The second type tends to manifest in the early 40s, and those patients tend not to have a family history of the condition. Rather, this type of psoriasis tends to be more associated with metabolic syndrome, diabetes, or hypertension.Dr. Blauvelt then begins delving into some of the well-known influences on psoriasis, including stress, infections like strep throat, and certain medications. He specifically mentions lithium and interferon stimulators, remarking that Aldara cream can stimulate psoriasis locally.He comments that the most common influences on psoriasis he has seen in his career have been strep throat, stress, and cold weather. He advises patients that any kind of stressor on the body, whether emotional or physical stress from temperature, medication, or infection, can trigger the psoriasis immune response.Key points<ul><li>Influences on psoriasis can include stress, infections, and certain medications</li><li>Lithium and interferon stimulators can affect psoriasis</li><li>Cold weather can also trigger the psoriasis immune response</li></ul>Comorbidities of psoriasisDr. Blauvelt comments that the list of comorbidities associated with psoriasis has become quite long and can be overwhelming for healthcare providers who are unsure how to counsel patients on this topic.He describes his approach to speaking with patients and how he always discusses the 2 most important psoriasis comorbidities, psoriatic arthritis and heart disease, at their first visit. When discussing psoriatic arthritis, he explains that it is the most common comorbidity and will affect treatment choice, and that is an important facet for patients to consider and understand. In his experience, some patients with psoriasis are unaware that they are at risk for arthritis and thus it should be discussed early on.Dr. Blauvelt also makes sure to discuss heart disease with his patients and emphasize the seriousness of it. He references the literature that is now available on psoriasis as an independent risk factor for heart disease and says it also suggests that the risk of heart disease can be reduced if an impact can be made on the skin.He mentions large databases that suggest TNF blockers may reduce the risk of cardiovascular events but that we don’t yet have that same kind of data for IL-17s and IL-23s. He also references studies conducted at the NIH that put patients on biologics for one year and measured their atherosclerotic plaques. Those studies demonstrated that IL-17 blockers were the best class of drugs in terms of improving atherosclerosis in patients with psoriasis. While they don’t prevent heart attack and stroke, it’s strong evidence that these therapies are having positive outcomes.Key points<ul><li>The long list of comorbidities associated with psoriasis can make it overwhelming to counsel patients</li><li>The 2 most important comorbidities to discuss with patients are psoriatic arthritis and heart disease</li><li>Psoriatic arthritis should be discussed with patients at their first visit, since it’s the most common comorbidity and can affect treatment choice</li><li>Literature suggests that psoriasis is an independent risk factor for heart disease and that the risk of heart disease can be reduced if an impact can be made on the skin</li><li>Large databases suggest TNF blockers may reduce risk of cardiovascular events</li><li>NIH studies demonstrated that IL-17 blockers were the best class of drugs in improving atherosclerosis in patients with psoriasis</li></ul>Mental health as a comorbidity of psoriasisDr. Han continues the conversation by asking Dr. Blauvelt his thoughts on mental health and psoriasis and how he approaches this discussion with patients.Dr. Blauvelt references his involvement in one of the first multidisciplinary clinics for psoriasis in the United States that included dermatology, rheumatology, and psychiatry. When he asked patients about their mental health, they often reported they were depressed and anxious due to the condition. He found many were hesitant to be referred to the psychiatry clinic because they felt that if their psoriasis cleared, their mental health would improve, which demonstrates there is a component to the condition that can cause angst and depression.He remarks that practitioners can assume quality of life is impaired for patients with psoriasis and that patients are likely to score poorly on quality-of-life measures and depression scales. He emphasizes that this should not be ignored and that it’s important to listen to patients and monitor for signs of severe depression and suicidal ideation.&nbsp;Dr. Han concludes by agreeing on the importance of listening and caring for the whole patient.Key points<ul><li>There is a component to psoriasis that can cause angst and depression among patients with the condition</li><li>Patients with psoriasis will often have impaired quality of life and score poorly on quality-of-life measures and depression scales</li><li>It’s vital to listen to patients and monitor them for signs of severe depression and suicidal ideation</li></ul>

What are some of the biggest challenges in treating molluscum contagiosum?

Can the 40-GEP test be performed on superficial biopsies?

How quickly does bimekizumab start working?

In Episode 64 of Derms and Conditions, our host, Dr James Q. Del Rosso, sits down with Dr Shane Chapman, Chairman of the Department of Dermatology at Dartmouth Hitchcock Medical Center, to discuss nonsurgical approaches to treating nonmelanoma skin cancer.

Shane Chapman, MD

dermsquared-derms-conditions-podcast-thumbs.png

Derms and Conditions Podcast

Beyond the Knife: Practical Nonsurgical Options for Skin Cancer

In Episode 63 of Derms and Conditions, our host, James Q. Del Rosso, DO, sits down with Adam Friedman, MD, to discuss some important topics in dermatology, including a comprehensive resource for portraying skin conditions and his research findings relating to sensitive skin.

Adam Friedman, MD

What is Dr Adam Friedman Up To Now?

In this episode of Derms and Conditions, Dr Jim Del Rosso and Dr Gary Goldenberg discuss some of the highlights from the meeting. These include recent FDA approvals such as bimekizumab for psoriasis and the triple topical combination for acne vulgaris, the newer nonsteroidal topical agents, tapinarof and roflumilast, and their relevant clinical use, the significance of narrow-spectrum oral antibiotic therapy with sarecycline as compared to other oral tetracycline with regard to antibiotic resistance, and physical devices such as laser systems used to treat acne vulgaris.&nbsp; &nbsp;

Gary Goldenberg, MD

Live From Las Vegas! Greatest Hits from Fall Clinical Dermatology 2023

Join the leading experts as they go in-depth on some of the most important topics in dermatology. In this special feature, they give their invaluable insights into the mechanism of disease of psoriasis.

Discourses in Dermatology

Discourses in Dermatology - Genetics Comorbidities (Video 2)

Welcome to Dermbits! Watch short videos of KOLs answering your questions

Discourses in Dermatology: New episode!

Check out our new series: Discourses in Dermatology

Discourses in Dermatology: New expert series on psoriasis

Registration Open for Fall Clinical '24!

The leading platform for dermatology professionals to elevate patient care

Compelling clinical cases

Listen to our experts on the go

Hear what the experts are saying

Latest Expert Videos